Archive for September, 2010

ArthroCare Receives FDA Clearance for Parallax Contour Vertebral Augmentation Device

ArthroCare CorpArthroCare Corp. announced that it has received clearance from the FDA to market its Parallax(R) Contour(R) Vertebral Augmentation Device (Contour) specifically for void creation in a vertebral body followed by injection of bone cement. Vertebral body void creation followed by bone cement augmentation is commonly used to treat painful vertebral compression fractures. The Contour device is indicated for use during kyphoplasty or vertebral augmentation procedures to create a void in the vertebral body.

Read the full story here

Antibacterial Patch For Soft Tissue Repair

TYRX IncTYRX, Inc. introduces AIGISRx® ST, its antibacterial product for the surgical repair of damaged or ruptured soft tissue. TYRX had previously received 510(k) clearance to market a product for hernia repair and other abdominal soft tissue deficiencies. The new clearance adds the use as a soft tissue patch to reinforce soft tissue where weakness exists and for the surgical repair of damaged or ruptured soft tissue.

Read the full story here

Spectrum Surgical Instruments Corp. Releases Instrument Processing Essentials Catalog

Spectrum Surgical Instruments CorpSpectrum Surgical Instruments Corp. is proud to announce that its new, Processing Essentials Catalog 9th Edition is now available. The full-color, 76-page catalog features many new products for surgery and central sterile supply — from surgical instrument cleaning brushes, instrument education, inspection and sharpness testing aides — to instrument trays, accessories, and protection devices.

Read the full story here

Integra LifeSciences Announces Launch of New Surgical Spine Instruments

Integra LifesciencesIntegra LifeSciences Holdings Corporation has announced the introduction of a new line of extended length and “detachable” Ruggles(TM) kerrison rongeurs, which are key instruments used in a variety of neuro and spine surgeries. The Ruggles(TM) kerrison rongeurs with a detachable feature received 510(k) clearance from the United States Food and Drug Administration (FDA). The new feature allows for easier cleaning, and special coatings help preserve the instrument’s sharpness.

Read the full story here

MicroAire Surgical Instruments Acquires Endotine(R) (Formerly Owned by Coapt Systems)

microaireMicroAire Surgical Instruments announced the acquisition of Endotine® bioabsorbable, soft-tissue fixation systems for facial aesthetic surgery. Endotine® is a patented system that allows surgeons to attach soft tissue to bone, or to other soft tissue — using special tines instead of sutures — thereby avoiding the tissue-strain associated with sutures. Although Endotine® devices have the holding power of multiple sutures; the system has more in common with hook-and-loop systems, than with traditional needle and thread.

Read the full story here

3M to buy patient warming products maker Arizant for $810 million

3M3M Co is making it third acquisition in less than a month by proposing to buy Arizant, a maker of patient warming products to prevent hypothermia during surgery, for $810 million in cash. Its products include Bair Hugger therapy, the Bair Paws patient adjustable warming system, and the Ranger blood and fluid warming systems. Arizant products help maintain normal body temperature, known as normothermia which help prevent surgical site infections.

Read the full story here

Cardiovascular Surgery Devices Market is Forecast to Reach 2.4 billion dollars in 2016

Cardiovascular SurgeryThe global market for cardiovascular surgery devices was valued at $2 billion in 2009, and is forecast to grow at a Compound Annual Growth Rate (CAGR) of 3% to reach $2.4 billion in 2016. The market is expected to be driven by patient population suffering from Coronary Artery Disease (CAD) and their increased awareness and safety of cardiovascular surgery over Percutaneous Coronary Intervention (PCI) in some cases, such as three vessel coronary artery disease.

Read the full story here

Monteris Medical raises 3.4M Dollars for brain surgery device

Monteris Medical IncMonteris Medical Inc. has raised $3.4 million in equity for a device that enables minimally invasive laser surgery for brain tumors. Monteris’ AutoLITT System received clearance for use in neurosurgery from the FDA last year. The AutoLITT procedure uses an MRI to guide a laser that allows doctors to watch and adjust as they heat glioblastoma multiforme (GBM) tumors, reduce them to a pasty state and remove the tumor.

Read the full story here